Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind EV71 vaccine trial in 3–5-year-old children
CTR20192345Phase 3Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Inactivated Enterovirus Type 71 Vaccine (Vero Cell), sponsored by Wuhan Institute of Biological Products. Started Nov 2019; status: completed.
02
Drugs
Inactivated Enterovirus Type 71 Vaccine (Vero Cell)
Beyond the preview
Go deeper on CTR20192345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192345.